Cointime

7 Hills Pharma

company

About

7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.

  • 1 - 10

Highlights

Total Funding Amount
$2M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
1 - 10
Operating Status
Active

7 Hills Pharma LLC is an immuno-oncology company developing drugs to treat drug resistant cancers. In spite of the unprecedented cure rates in rare cancers, the promise of immunotherapy and cell therapy is yet to be realized for solid tumors such as lung, colon, and other cancers. 7 Hills is developing cost-effective technologies that modulate the immune system to increase the effectiveness of immune checkpoint blockade, adoptive cell therapy, and cord blood transplant to treat solid tumors and orphan genetic diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2M
7 Hills Pharma has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on Jun 19, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 19, 2018 Grant $2M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
7 Hills Pharma is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
Содержание
компания